Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
Open accessThe DOI matches its Crossref record; 25 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as effective as total mastectomy for the treatment of invasive breast cancer. METHODS: A total of 1851 women for whom follow-up data were available and nodal status was known underwent randomly assigned treatment consisting of total mastectomy, lumpectomy alone, or lumpectomy and breast irradiation. Kaplan-Meier and cumulative-incidence estimates of the outcome were obtained. RESULTS: The cumulative incidence of recurrent tumor in the ipsilateral breast was 14.3 percent in the women who underwent lumpectomy and breast irradiation, as compared with 39.2 percent in the women who underwent lumpectomy without irradiation (P<0.001). No significant differences were observed among the three groups of women with respect to disease-free survival, distant-disease-free survival, or overall survival. The hazard ratio for death among the women who underwent lumpectomy alone, as compared with those who underwent total mastectomy, was 1.05 (95 percent confidence interval, 0.90 to 1.23; P=0.51). The hazard ratio for death among the women who underwent lumpectomy followed by breast irradiation, as compared with those who underwent total mastectomy, was 0.97 (95 percent confidence interval, 0.83 to 1.14; P=0.74). Among the lumpectomy-treated women whose surgical specimens had tumor-free margins, the hazard ratio for death among the women who underwent postoperative breast irradiation, as compared with those who did not, was 0.91 (95 percent confidence interval, 0.77 to 1.06; P=0.23). Radiation therapy was associated with a marginally significant decrease in deaths due to breast cancer. This decrease was partially offset by an increase in deaths from other causes. CONCLUSIONS: Lumpectomy followed by breast irradiation continues to be appropriate therapy for women with breast cancer, provided that the margins of resected specimens are free of tumor and an acceptable cosmetic result can be obtained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has resulted in improved outcomes in a number of different cancers (2, 342–350).”
From Adrenocortical carcinoma (2014) · cites this paper as [344]
In the citing paper
“Breast-conserving surgery combined with radiation therapy is standard treatment for early stage breast cancer and provides equivalent survival to mastectomy [20-27].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [20]
In the citing paper
“and it can be greatly reduced by radiotherapy. 4,5”
In the citing paper
“The risk of recurrence in a conserved breast can be substantial even in node-negative disease that has been confirmed by axillary clearance”
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121101 · Cited by 2,194
Self-citationVeronesi, U., Saccozzi, R., Del Vecchio, M., Banfi, A., Clemente, C., De Lena, M., Gallus, G., Greco, M., Luini, A., Marubini, E., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050102 · Cited by 1,599
Research works printed but not linked: 4
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
- Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Bethesda, Md.: National Cancer Institute, 1992:19-25. (NIH publication no. 90-3187.)
- 10.1007/BF01655182 · DOI
- Veronesi U, 1983, Int Adv Surg Oncol, 6, 141
Cited by
Items 101–200 of 1,005
Predictors of Re-excision among Women Undergoing Breast-Conserving Surgery for Cancer
Waljee, J. F., Hu, E. S., Newman, L. A., & Alderman, A. K. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9777-x · Cited by 265
Houssami, N., & Hayes, D. F. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20028 · Cited by 267
Curigliano, G., Burstein, H. J., Gnant, M., Loibl, S., Cameron, D., Regan, M. M., Denkert, C., Poortmans, P., Weber, W. P., Thürlimann, B., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.08.017 · Cited by 241
Barriers to rehabilitation following surgery for primary breast cancer
Cheville, A. L., & Tchou, J. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20782 · Cited by 251
Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. H. M., Nelson, D. O., Clarke, C. A., & Gomez, S. L. (2014) · JAMA · doi:10.1001/jama.2014.10707 · Cited by 255
“1,2 There is no randomized trial evidence to inform whether bilateral mastectomy improves survival, and it is unlikely that such a trial will ever be performed.”
Kirova, Y. M., Vilcoq, J. R., Asselain, B., Sastre‐Garau, X., & Fourquet, A. (2005) · Cancer · doi:10.1002/cncr.21223 · Cited by 251
Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery
Cabioglu, N., Hunt, K. K., Sahin, A. A., Kuerer, H. M., Babiera, G. V., Singletary, S. E., Whitman, G. J., Ross, M. I., Ames, F. C., Feig, B. W., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9236-0 · Cited by 251
Suit, H., Goldberg, S., Niemierko, A., Ancukiewicz, M., Hall, E., Goitein, M., Wong, W., & Paganetti, H. (2007) · Radiation Research · doi:10.1667/rr0527.1 · Cited by 251
Calligaris, D., Caragacianu, D., Liu, X., Norton, I., Thompson, C. J., Richardson, A. L., Golshan, M., Easterling, M. L., Santagata, S., Dillon, D. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408129111 · Cited by 247
“Results from seven large randomized prospective studies, with the largest two having over 20 y of follow-up, have shown equal survival when comparing BCS coupled with whole-breast radiation and mastectomy (2, 3).”
BackgroundYao, K., Stewart, A. K., Winchester, D. J., & Winchester, D. P. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1091-3 · Cited by 241
“4% in the total mastectomy, lumpectomy alone, and lumpectomy plus irradiation arms, respectively, at 20-year follow-up.(30) One in 25 breast cancer survivors will develop a second primary breast cancer, either in the index breast or the contralateral breast, but contralateral cancers account for only 2.”
BackgroundLocoregional recurrence risk after lipofilling in breast cancer patients
Petit, J. Y., Botteri, E., Lohsiriwat, V., Rietjens, M., De Lorenzi, F., Garusi, C., Rossetto, F., Martella, S., Manconi, A., Bertolini, F., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr158 · Cited by 239
“It has been demonstrated that the majority of local relapses after mastectomy occurs within 5 years and reach a plateau phrase after >5 years [32–34].”
BackgroundCutaneous Angiosarcoma Following Breast-conserving Surgery and Radiation: An Analysis of 27 Cases
Billings, S. D., McKenney, J. K., Folpe, A. L., Hardacre, M. C., & Weiss, S. W. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126055.33916.0b · Cited by 245
Benitez, P. R., Keisch, M. E., Vicini, F., Stolier, A., Scroggins, T., Walker, A., White, J., Hedberg, P., Hebert, M., Arthur, D., et al. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.06.010 · Cited by 241
Hartmann, L. C., Radisky, D. C., Frost, M. H., Santen, R. J., Vierkant, R. A., Benetti, L. L., Tarabishy, Y., Ghosh, K., Visscher, D. W., & Degnim, A. C. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0222 · Cited by 234
Formenti, S. C., Truong, M. T., Goldberg, J. D., Mukhi, V., Rosenstein, B., Roses, D., Shapiro, R., Guth, A., & Dewyngaert, J. K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.04.036 · Cited by 236
Jones, H. A., Antonini, N., Hart, A. A. M., Peterse, J. L., Horiot, J.-C., Collin, F., Poortmans, P. M., Oei, S. B., Collette, L., Struikmans, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5764 · Cited by 239
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures
Desch, C. E., McNiff, K. K., Schneider, E. C., Schrag, D., McClure, J., Lepisto, E., Donaldson, M. S., Kahn, K. L., Weeks, J. C., Ko, C. Y., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5068 · Cited by 231
Veronesi, U., Orecchia, R., Luini, A., Galimberti, V., Zurrida, S., Intra, M., Veronesi, P., Arnone, P., Leonardi, M. C., Ciocca, M., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1115-5 · Cited by 235
Redline, S., Amin, R., Beebe, D., Chervin, R. D., Garetz, S. L., Giordani, B., Marcus, C. L., Moore, R. H., Rosen, C. L., Arens, R., et al. (2011) · Sleep · doi:10.5665/sleep.1388 · Cited by 227
Oncoplastic Breast Surgery for Cancer: Analysis of 540 Consecutive Cases
Fitoussi, A. D., Berry, M. G., Famà, F., Falcou, M.-C., Curnier, A., Couturaud, B., Reyal, F., & Salmon, R. J. (2010) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181c82d3e · Cited by 227
Waljee, J. F., Rogers, M. A. M., & Alderman, A. K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5472 · Cited by 225
Second international consensus guidelines for breast cancer in young women (BCY2)
Paluch-Shimon, S., Pagani, O., Partridge, A. H., Bar-Meir, E., Fallowfield, L., Fenlon, D., Friedman, E., Gelmon, K., Gentilini, O., Geraghty, J., et al. (2016) · The Breast · doi:10.1016/j.breast.2015.12.010 · Cited by 227
Collette, S., Collette, L., Budiharto, T., Horiot, J.-C., Poortmans, P. M., Struikmans, H., Van den Bogaert, W., Fourquet, A., Jager, J. J., Hoogenraad, W., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.032 · Cited by 224
Jatoi, I., & Proschan, M. A. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000156922.58631.d7 · Cited by 227
Can Women With Early-Stage Breast Cancer Make an Informed Decision for Mastectomy?
Collins, E. D., Moore, C. P., Clay, K. F., Kearing, S. A., O'Connor, A. M., Llewellyn-Thomas, H. A., Barth, R. J., & Sepucha, K. R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6215 · Cited by 220
Datta, N. R., Puric, E., Klingbiel, D., Gomez, S., & Bodis, S. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.12.361 · Cited by 220
Blamey, R. W., Bates, T., Chetty, U., Duffy, S. W., Ellis, I. O., George, D., Mallon, E., Mitchell, M. J., Monypenny, I., Morgan, D. A. L., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.031 · Cited by 222
Pötter, R., Gnant, M., Kwasny, W., Tausch, C., Handl-Zeller, L., Pakisch, B., Taucher, S., Hammer, J., Luschin-Ebengreuth, G., Schmid, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.045 · Cited by 222
“ge at diagnosis (y) 50 9 (2) 5 (1) 50–59 115 (28) 115 (28) 60–69 145 (35) 149 (36) 70 145 (35) 148 (35) umor size pT1b 143 (35) 136 (33) pT1c 228 (55) 246 (59) pT2 43 (10) 35 (8) athological grade G1 135 (33) 138 (33) G2 257 (62) 259 (62) Gx 22 (5) 20 (5) strogen receptor status 252 (61) 278 (67) / 156 (38) 134 (32) N…”
BackgroundAre Mastectomy Rates Really Increasing in the United States?
Habermann, E. B., Abbott, A., Parsons, H. M., Virnig, B. A., Al-Refaie, W. B., & Tuttle, T. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6774 · Cited by 223
Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer
Patt, D. A., Goodwin, J. S., Kuo, Y.-F., Freeman, J. L., Zhang, D. D., Buchholz, T. A., Hortobagyi, G. N., & Giordano, S. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.755 · Cited by 225
Quality indicators in breast cancer care: An update from the EUSOMA working group
Biganzoli, L., Marotti, L., Hart, C. D., Cataliotti, L., Cutuli, B., Kühn, T., Mansel, R. E., Ponti, A., Poortmans, P., Regitnig, P., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.017 · Cited by 216
Polgár, C., Major, T., Fodor, J., Németh, G., Orosz, Z., Sulyok, Z., Udvarhelyi, N., Somogyi, A., Takácsi-Nagy, Z., Lövey, K., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.012 · Cited by 222
Wilke, L. G., Czechura, T., Wang, C., Lapin, B., Liederbach, E., Winchester, D. P., & Yao, K. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.926 · Cited by 223
Vicini, F. A., Remouchamps, V., Wallace, M., Sharpe, M., Fayad, J., Tyburski, L., Letts, N., Kestin, L., Edmundson, G., Pettinga, J., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01573-6 · Cited by 223
Oncological and cosmetic outcomes of oncoplastic breast conserving surgery
Asgeirsson, K. S., Rasheed, T., McCulley, S. J., & Macmillan, R. D. (2005) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2005.05.010 · Cited by 219
Heil, J., Kuerer, H. M., Pfob, A., Rauch, G., Sinn, H. P., Golatta, M., Liefers, G. J., & Vrancken Peeters, M. J. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.012 · Cited by 218
A review of clinical aspects of breast cancer
Libson, S., & Lippman, M. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.852971 · Cited by 211
Ashrafizadeh, M., Zarrabi, A., Bigham, A., Taheriazam, A., Saghari, Y., Mirzaei, S., Hashemi, M., Hushmandi, K., Karimi‐Maleh, H., Nazarzadeh Zare, E., et al. (2023) · Medicinal Research Reviews · doi:10.1002/med.21971 · Cited by 207
“It has been reported that among 10,801 breast cancer patients who have undergone mass resection, application of radiotherapy significantly improves their survival rate and decreases their 10‐year recurrence rate.(10) Utilization of nanoradiosensitizers composed of high atomic number elements has been shown to signific…”
BackgroundAdvanced Nanotechnology Leading the Way to Multimodal Imaging‐Guided Precision Surgical Therapy
Wang, C., Fan, W., Zhang, Z., Wen, Y., Xiong, L., & Chen, X. (2019) · Advanced Materials · doi:10.1002/adma.201904329 · Cited by 213
Evidence-based recommendations on categories for extent of resection in diffuse glioma
Karschnia, P., Vogelbaum, M. A., van den Bent, M., Cahill, D. P., Bello, L., Narita, Y., Berger, M. S., Weller, M., & Tonn, J.-C. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.03.002 · Cited by 212
“Whereas randomized trials on extent of resection above tumour borders can be pursued in most solid tumours such as breast cancer [73], such studies are hard to design and to ethically justify in neuro-oncological patients (particularly when it comes to leave surgically targetable tumour tissue in situ).”
BackgroundOlson, T. P., Harter, J., Muñoz, A., Mahvi, D. M., & Breslin, T. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9437-1 · Cited by 213
Quality indicators in breast cancer care
Rosselli Del Turco, M., Ponti, A., Bick, U., Biganzoli, L., Cserni, G., Cutuli, B., Decker, T., Dietel, M., Gentilini, O., Kuehn, T., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.119 · Cited by 207
What is an Adequate Margin for Breast-Conserving Surgery? Surgeon Attitudes and Correlates
Azu, M., Abrahamse, P., Katz, S. J., Jagsi, R., & Morrow, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0765-1 · Cited by 211
“While the NSABP-06 study used the definition of tumor cells not touching ink, other randomized trials appeared to employ more widely clear margins.(1) Entrance criteria for the Institute Gustave Roussy study included a gross margin of 2 cm, while the Milan I trial specified removal of a ‘‘quadrant’’ of the TABLE 3 Rel…”
MethodVariability Among Breast Radiation Oncologists in Delineation of the Postsurgical Lumpectomy Cavity
Landis, D. M., Luo, W., Song, J., Bellon, J. R., Punglia, R. S., Wong, J. S., Killoran, J. H., Gelman, R., & Harris, J. R. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.026 · Cited by 213
The severity, outcome and challenges of breast cancer in Nigeria
Adesunkanmi, A. R. K., Lawal, O. O., Adelusola, K. A., & Durosimi, M. A. (2006) · The Breast · doi:10.1016/j.breast.2005.06.008 · Cited by 210
Taghian, A., Mohiuddin, M., Jagsi, R., Goldberg, S., Ceilley, E., & Powell, S. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000157272.04803.1b · Cited by 209
The Lancet Breast Cancer Commission
Coles, C. E., Earl, H., Anderson, B. O., Barrios, C. H., Bienz, M., Bliss, J. M., Cameron, D. A., Cardoso, F., Cui, W., Francis, P. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00747-5 · Cited by 178
Haloua, M. H., Krekel, N. M. A., Winters, H. A. H., Rietveld, D. H. F., Meijer, S., Bloemers, F. W., & van den Tol, M. P. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182888782 · Cited by 201
Accelerated Partial Breast Irradiation (APBI): A review of available techniques
Njeh, C. F., Saunders, M. W., & Langton, C. M. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-90 · Cited by 205
Effects of breast cancer surgery and surgical side effects on body image over time
Collins, K. K., Liu, Y., Schootman, M., Aft, R., Yan, Y., Dean, G., Eilers, M., & Jeffe, D. B. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1077-7 · Cited by 193
Celaya, M. O., Rees, J. R., Gibson, J. J., Riddle, B. L., & Greenberg, E. R. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0025-7 · Cited by 199
“The use of BCS without radiation may put women at increased risk of recurrence [ 6 ] and lower survival [32].”
BackgroundKrekel, N. M., Haloua, M. H., Lopes Cardozo, A. M., de Wit, R. H., Bosch, A. M., de Widt-Levert, L. M., Muller, S., van der Veen, H., Bergers, E., de Lange de Klerk, E. S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70527-2 · Cited by 194
Pierce, L. J., Phillips, K.-A., Griffith, K. A., Buys, S., Gaffney, D. K., Moran, M. S., Haffty, B. G., Ben-David, M., Kaufman, B., Garber, J. E., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0894-z · Cited by 199
“Breast-conserving therapy (BCT), defined as surgical excision and radiotherapy (RT), has been shown in multiple trials to result in comparable rates of tumor control and survival as mastectomy (M) in women with sporadic early stage disease [3,4].”
Predicting a local recurrence after breast-conserving therapy by gene expression profiling
Nuyten, D. S., Kreike, B., Hart, A. A., Chi, J.-T. A., Sneddon, J. B., Wessels, L. F., Peterse, H. J., Bartelink, H., Brown, P. O., Chang, H. Y., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1614 · Cited by 202
Meric, F., Mirza, N. Q., Vlastos, G., Buchholz, T. A., Kuerer, H. M., Babiera, G. V., Singletary, S. E., Ross, M. I., Ames, F. C., Feig, B. W., et al. (2003) · Cancer · doi:10.1002/cncr.11222 · Cited by 198
Gu, J., Groot, G., Boden, C., Busch, A., Holtslander, L., & Lim, H. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.12.013 · Cited by 190
Accelerated Partial Breast Irradiation As a Part of Breast Conservation Therapy
Arthur, D. W., & Vicini, F. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.045 · Cited by 197
Offersen, B. V., Overgaard, M., Kroman, N., & Overgaard, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.08.005 · Cited by 196
“Some large trials have tried to select women with an anticipated particularly low risk of relapse based on tumor and biological aspects and randomized these women to ± radiotherapy combined with Tamoxifen (excluding young patients, including pT1–2, pN0, low-moderate malignancy grade, oestrogen receptor positive, negat…”
BackgroundSkin Toxicity During Breast Irradiation: Pathophysiology and Management
Harper, J. L., Franklin, L. E., Jenrette, J. M., & Aguero, E. G. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000140866.97278.87 · Cited by 194
“Many women with early stage breast cancer are candidates for breast conservation therapy (BCT), which combines conservative surgery and radiotherapy.(2) In more advanced breast cancer requiring mastectomy, adjuvant radiotherapy has been shown to improve overall survival.”
BackgroundLocalization techniques for guided surgical excision of non-palpable breast lesions
Chan, B. K., Wiseberg-Firtell, J. A., Jois, R. H., Jensen, K., & Audisio, R. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009206.pub2 · Cited by 190
van Roozendaal, L. M., Vane, M. L. G., van Dalen, T., van der Hage, J. A., Strobbe, L. J. A., Boersma, L. J., Linn, S. C., Lobbes, M. B. I., Poortmans, P. M. P., Tjan-Heijnen, V. C. G., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3443-x · Cited by 188
Breast cancer treatment: A phased approach to implementation
Mutebi, M., Anderson, B. O., Duggan, C., Adebamowo, C., Agarwal, G., Ali, Z., Bird, P., Bourque, J., DeBoer, R., Gebrim, L. H., et al. (2020) · Cancer · doi:10.1002/cncr.32910 · Cited by 187
“breast-conserving surgery offers oncologic outcomes similar to those from a mastectomy.(22,23) Adjuvant ra-”
Polgár, C., Major, T., Fodor, J., Sulyok, Z., Somogyi, A., Lövey, K., Németh, G., & Kásler, M. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.019 · Cited by 193
“Over the last decades, breast-conserving surgery (BCS) followed by whole breast irradiation (WBI) became the standard of care for the treatment of early-stage breast carcinoma [1,2].”
BackgroundUpdate on Preoperative Breast Localization
Hayes, M. K. (2017) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2016.12.012 · Cited by 187
Cardoso, M. J., Cardoso, J., Amaral, N., Azevedo, I., Barreau, L., Bernardo, M., Christie, D., Costa, S., Fitzal, F., Fougo, J. L., et al. (2007) · The Breast · doi:10.1016/j.breast.2007.05.002 · Cited by 188
Khouri, R. K., Rigotti, G., Khouri, R. K., Cardoso, E., Marchi, A., Rotemberg, S. C., Baker, T. J., & Biggs, T. M. (2015) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0000000000001039 · Cited by 187
Vikström, J., Hjelstuen, M. H. B., Mjaaland, I., & Dybvik, K. I. (2011) · Acta Oncologica · doi:10.3109/0284186x.2010.512923 · Cited by 184
“Radiotherapy following breast conserving surgery signifi cantly reduces the risk of breast and axillary recurrence and results in long-term survival similar to that after mastectomy [1,2].”
BackgroundCunnick, G. H., & Mokbel, K. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2004.02.004 · Cited by 188
Surgical Margins in Lumpectomy for Breast Cancer — Bigger Is Not Better
Morrow, M., Harris, J. R., & Schnitt, S. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmsb1202521 · Cited by 189
Current concepts in clinical radiation oncology
Orth, M., Lauber, K., Niyazi, M., Friedl, A. A., Li, M., Maihöfer, C., Schüttrumpf, L., Ernst, A., Niemöller, O. M., & Belka, C. (2014) · Radiation and Environmental Biophysics · doi:10.1007/s00411-013-0497-2 · Cited by 178
“For breast cancer, it was shown that breast-conserving surgery in combination with adju- vant radiotherapy results in survival rates that are equal to mastectomy (Fisher et al. 2002) and that omitting adju- vant radiotherapy causes a decrease by 4 % in patient survival (Darby et al. 2011).”
BackgroundGradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0060 · Cited by 183
What Is Known about Breast Cancer in Young Women?
Zhu, J. W., Charkhchi, P., Adekunte, S., & Akbari, M. R. (2023) · Cancers · doi:10.3390/cancers15061917 · Cited by 225
Antonini, N., Jones, H., Horiot, J. C., Poortmans, P., Struikmans, H., den Bogaert, W. V., Barillot, I., Fourquet, A., Jager, J., Hoogenraad, W., et al. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.09.014 · Cited by 185
“In the NSABP B-06 trial, whole-breast irradiation (50 Gy) after complete microscopic excision reduced the recurrence rate from 39% to 14% [4].”
BackgroundMethodSchubert, L. K., Gondi, V., Sengbusch, E., Westerly, D. C., Soisson, E. T., Paliwal, B. R., Mackie, T. R., Mehta, M. P., Patel, R. R., Tomé, W. A., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.01.004 · Cited by 182
Berman, A. T., Thukral, A. D., Hwang, W.-T., Solin, L. J., & Vapiwala, N. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.11.001 · Cited by 180
Predictive factors for late normal tissue complications following radiotherapy for breast cancer
Lilla, C., Ambrosone, C. B., Kropp, S., Helmbold, I., Schmezer, P., von Fournier, D., Haase, W., Sautter-Bihl, M.-L., Wenz, F., & Chang-Claude, J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9480-9 · Cited by 183
“Radiotherapy is commonly applied after breast-conserving surgery to reduce the risk of locoregional recurrence of breast cancer and has been shown to be as effective as radical mastectomy [1].”
BackgroundJanz, N. K., Mujahid, M., Lantz, P. M., Fagerlin, A., Salem, B., Morrow, M., Deapen, D., & Katz, S. J. (2005) · Quality of Life Research · doi:10.1007/s11136-005-0288-6 · Cited by 180
“The majority of women with early stage breast cancer have three surgical choices that carry the same survival: breast conserving surgery (BCS) with radiation, mastectomy only, and mastectomy with reconstruction [1, 2].”
BackgroundKomoike, Y., Akiyama, F., Iino, Y., Ikeda, T., Akashi‐Tanaka, S., Ohsumi, S., Kusama, M., Sano, M., Shin, E., Suemasu, K., et al. (2006) · Cancer · doi:10.1002/cncr.21551 · Cited by 182
Chen, P. Y., Vicini, F. A., Benitez, P., Kestin, L. L., Wallace, M., Mitchell, C., Pettinga, J., & Martinez, A. A. (2006) · Cancer · doi:10.1002/cncr.21681 · Cited by 179
Arriagada, R., Lê, M. G., Guinebretière, J.-M., Dunant, A., Rochard, F., & Tursz, T. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg452 · Cited by 179
“However, longterm results in breast-conserving surgery (BCS) series are cause for concern, essentially because of local control rates [6, 9–12].”
BackgroundResultInfluentialHughes, J. H., Mason, M. C., Gray, R. J., McLaughlin, S. A., Degnim, A. C., Fulmer, J. T., Pockaj, B. A., Karstaedt, P. J., & Roarke, M. C. (2008) · The Breast Journal · doi:10.1111/j.1524-4741.2007.00546.x · Cited by 178
“landmark NSABP B-06 and Milan trials (10,11) each have follow-up of greater than 20 years.”
BackgroundAxillary Node Interventions in Breast Cancer: A Systematic Review
Rao, R., Euhus, D., Mayo, H. G., & Balch, C. (2013) · JAMA · doi:10.1001/jama.2013.277804 · Cited by 172
Fennessy, M., Bates, T., MacRae, K., Riley, D., Houghton, J., & Baum, M. (2004) · British Journal of Surgery · doi:10.1002/bjs.4603 · Cited by 175
Hawley, S. T., Griggs, J. J., Hamilton, A. S., Graff, J. J., Janz, N. K., Morrow, M., Jagsi, R., Salem, B., & Katz, S. J. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp271 · Cited by 176
Radecka, B., & Litwiniuk, M. (2016) · Ginekologia Polska · doi:10.5603/gp.2016.0062 · Cited by 160
The American Brachytherapy Society consensus statement for accelerated partial breast irradiation
Shah, C., Vicini, F., Wazer, D. E., Arthur, D., & Patel, R. R. (2013) · Brachytherapy · doi:10.1016/j.brachy.2013.02.001 · Cited by 177
“With regard to the invasive lobular carcinomas (ILC), although there still remains limited data regarding APBI and lobular carcinomas, the guideline was modified to include lobular carcinomas based on (1) the”
Brachtel, E. F., Rusby, J. E., Michaelson, J. S., Chen, L. L., Muzikansky, A., Smith, B. L., & Koerner, F. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8785 · Cited by 176
Malmström, P., Holmberg, L., Anderson, H., Mattsson, J., Jönsson, P.-E., Tennvall-Nittby, L., Balldin, G., Lovén, L., Svensson, J.-H., Ingvar, C., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00324-1 · Cited by 174
“A 20 year follow-up has clearly demonstrated the safety of this approach [24,25].”
BackgroundSmith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Julian, T. B., Marks, L. B., Todor, D. A., Vicini, F. A., et al. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.02.066 · Cited by 172
Extreme Oncoplasty: Breast Conservation for Patients Who Need Mastectomy
Silverstein, M. J., Savalia, N., Khan, S., & Ryan, J. (2015) · The Breast Journal · doi:10.1111/tbj.12356 · Cited by 169
“recurrence rates, survival at 20 years was similar (1,3).”
BackgroundBreast Cancer: A Review for the General Surgeon
Matsen, C. B., & Neumayer, L. A. (2013) · JAMA Surgery · doi:10.1001/jamasurg.2013.3393 · Cited by 167
The Obligation to Participate in Biomedical Research
Schaefer, G. O. (2009) · JAMA · doi:10.1001/jama.2009.931 · Cited by 171
Accuracy of Intraoperative Frozen-Section Analysis of Breast Cancer Lumpectomy-Bed Margins
Cendán, J. C., Coco, D., & Copeland, E. M. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.03.014 · Cited by 171
Nipple-Sparing Mastectomy in 99 Patients With a Mean Follow-up of 5 Years
Jensen, J. A., Orringer, J. S., & Giuliano, A. E. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1475-4 · Cited by 171
Rodríguez, N., Sanz, X., Dengra, J., Foro, P., Membrive, I., Reig, A., Quera, J., Fernández-Velilla, E., Pera, Ó., Lio, J., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.08.046 · Cited by 169
Evans, R. A. (2003) · Cancer · doi:10.1002/cncr.11792 · Cited by 173
Updates in the Treatment of Breast Cancer with Radiotherapy
Castaneda, S. A., & Strasser, J. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.01.013 · Cited by 168
Impact of Breast Cancer Surgery on the Self-Esteem and Sexual Life of Female Patients
Markopoulos, C., Tsaroucha, A., Kouskos, E., Mantas, D., Antonopoulou, Z., & Karvelis, S. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700122 · Cited by 169
de Ridder, J., de Wilt, J. H. W., Simmer, F., Overbeek, L., Lemmens, V., & Nagtegaal, I. (2016) · Oncotarget · doi:10.18632/oncotarget.10552 · Cited by 163
Long-term Results After Oncoplastic Surgery for Breast Cancer: A 10-year Follow-up
Clough, K. B., van la Parra, R. F. D., Thygesen, H. H., Levy, E., Russ, E., Halabi, N. M., Sarfati, I., & Nos, C. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002255 · Cited by 167
Metadata
- Authors
- Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N.
- Affiliations
- University of Pittsburgh (US)
- NSABP Foundation (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-10-17
- Volume
- 347
- Issue
- 16
- Pages
- 1233-1241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2067420088
- Semantic Scholar
- 4468d9b99c6cf981372c46aebe6895549bc34b70
- Cited by
- 6,249
- References
- 28
- Citations by year
- 2026: 190 · 2025: 212 · 2024: 241 · 2023: 306 · 2022: 302 · 2021: 328 · 2020: 320 · 2019: 290 · 2018: 284 · 2017: 289 · 2016: 334 · 2015: 340 · 2014: 318 · 2013: 331 · 2012: 321
- FWCI
- 52.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (U10-CA37377, U10CA069651, U10CA037377, U10CA069974, U10 CA 69651, U10-CA-69974)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- invasive breast cancer, total mastectomy, breast-conserving surgery, breast cancer radiotherapy, breast-conserving therapy, ipsilateral breast tumor recurrence, disease-free survival, overall survival, long-term outcomes
- MeSH terms
- Breast Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Mastectomy, Radical, Mastectomy, Segmental, Incidence, Survival Analysis, Randomized Controlled Trials as Topic, Neoplasms, Second Primary, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.